Reproductive Health News

The prevalence of maternal hepatitis C virus infection has significantly increased in the U.S. since the start of the opioid epidemic in 1998, according to results from a cross-sectional study published in JAMA Network Open.

Undergoing more cervical cancer screenings was associated with an increased risk for preterm birth among women aged 18 to 24 years, especially among those with hypertension or diabetes, researchers reported.

Use of a cervical pessary not only did not prevent preterm birth for women with a short cervix, but was associated with higher fetal or neonatal mortality rate, researchers reported in JAMA.

More fully integrating the midwifery model of care in philosophically aligned health care teams and institutions could be important in addressing disparities and the maternity care crisis in the U.S., according to a published expert review.

The FDA has granted 510(k) clearance to Nesa Medtech’s Fibroid Mapping Reviewer Application to aid physicians in diagnosing symptomatic uterine fibroids and planning of interventional procedures, according to a company press release.

County-level preterm birth risk was higher among women with more physical, social and health risk factors as measured by a novel county-level index to quantify maternal vulnerability to adverse outcomes.

Girls who began hormonal contraceptive treatment before age 18 years experienced greater risk for developing asthma than girls who did not, according to a study published in the Journal of Allergy and Clinical Immunology: In Practice.

Population-level severe maternal morbidity rate increases in the U.S. in the past decade were attributable to age-specific rate increases and might indicate worsening prepregnancy health status, researchers reported.

As the number of young cancer survivors continues to increase, so do the myriad of survivorship issues throughout their life span, including reproductive health concerns.

Women of childbearing age with hidradenitis suppurativa are often prescribed teratogenic medications, and the majority do not receive physician-led counsel on how these medications could impact childbearing, according to published data.